The intracellular parasite Leishmania is distributed worldwide and aff
ects more than 12 million people, Cases of leishmaniasis al-e increasi
ng and their treatment is complicated by the emergence of drug resista
nce, Understanding the molecular mechanisms of drug resistance should
permit the development of tests to detect resistance early during infe
ction, to suggest novel therapeutic avenues or to pinpoint novel intra
cellular targets, To control the infection more efficiently, a better
understanding of the mechanisms of intracellular survival is required,
It is now possible to introduce exogenous DNA into Leishmania using e
lectroporation, The transfected DNA can be maintained as an episome or
can integrate into the genome by homologous recombination. Gene targe
ting permits to inactivate genes that could yield attenuated parasites
for use in the generation of live vaccines, A better understanding of
the mechanisms used by the parasite to survive within the macrophages
and to subvert the immune response by altering the transductional mec
hanisms of the host cells, may lead to the identification of new cellu
lar targets from the parasite or the macrophage that will permit the d
evelopment of new therapies, Overall these studies should provide a be
tter understanding of the biology of this parasite which is necessary
for its control and eradication.